NanoSALV Catalytic 

Is a Health Canada approved Class II medical device indicated for use in the effective management of acute and chronic wounds across the full continuum of care. This includes: 

  • Early-Stage Prevention and Acute Wounds: Providing skin and/or minor wound support at early stages for low and high-risk patients, including diabetics, post-surgical site complications, the elderly, immunocompromised, and others, to minimize the progression into chronic, life-threatening wounds. 
  • Chronic and Advanced Stage Wounds: Management of severe/chronic wounds to stimulate endogenous healing and exit the stagnant wound phase; aiming to prevent amputation. 
  • Infection Protection: Providing a protective, broad-spectrum antimicrobial effect to control and minimize infection (resistant bacteria, viruses, fungi, yeast, biofilms) and reduce harmful impacts on healing or healthy cells. 
  • Post-Surgical Intervention: Providing post-surgical support to facilitate healing outcomes and minimize infection or re-infection and ulceration or re-ulceration for high-risk individuals. 

☑ Actively supports wound healing
☑ Reduces inflammation
☑ Protects against infection within the matrix
☑ Provides moisture management
☑ Manufactured in Canada